NK cells that were previously exposed to neuroblastoma (NB) can secrete exosomes containing NK cell receptors, such as CD56, KIR2DL2, and NKG2D receptors, which can subsequently stimulate normal NK cells, generating greater and more efficient cytotoxicity against NB tumor cells [45]. This evidence concerns the gene KLRD1 and neuroblastoma.